A new analysis from the Office of Inspector General found a similar net cost for drugs through vertically-integrated Part D plans compared to other plans. | A new analysis from the Office of Inspector General found a similar net cost for drugs through vertically-integrated Part D plans compared to other plans.
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
Healthcare costs continue to rise, making effective payer-provider collaboration more important than ever. Download this free…
Fewer than a third of people with commercial coverage say that their plans represent a "trusted partner" in their health,…
Drug spending is rising sharply, with high-cost GLP-1 medications driving nearly half of the incr | How RxSense helped a health…
LAS VEGAS — As drug costs and spending continue to rise, the demand for solutions opens the door to closer collaboration between…
Employers that have access to key data on their healthcare spending and costs are more likely to take steps to address…
The health insurance industry weathered a rough 2025, and the turnaround for some companies through the midpoint has surprised…
